Logo image of SUUN

SOLARBANK CORP (SUUN) Stock Fundamental Analysis

NASDAQ:SUUN - Nasdaq - CA83417Y1088 - Common Stock - Currency: USD

1.51  -0.04 (-2.58%)

After market: 1.58 +0.07 (+4.64%)

Fundamental Rating

2

Overall SUUN gets a fundamental rating of 2 out of 10. We evaluated SUUN against 51 industry peers in the Construction & Engineering industry. SUUN may be in some trouble as it scores bad on both profitability and health. SUUN is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SUUN had negative earnings in the past year.
SUUN had a negative operating cash flow in the past year.
SUUN Yearly Net Income VS EBIT VS OCF VS FCFSUUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

1.2 Ratios

With a Return On Assets value of -3.03%, SUUN is not doing good in the industry: 72.55% of the companies in the same industry are doing better.
With a Return On Equity value of -12.09%, SUUN is not doing good in the industry: 72.55% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.03%
ROE -12.09%
ROIC N/A
ROA(3y)-0.64%
ROA(5y)N/A
ROE(3y)-3.92%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SUUN Yearly ROA, ROE, ROICSUUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

SUUN's Gross Margin of 24.27% is fine compared to the rest of the industry. SUUN outperforms 74.51% of its industry peers.
In the last couple of years the Gross Margin of SUUN has declined.
SUUN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.59%
GM growth 5YN/A
SUUN Yearly Profit, Operating, Gross MarginsSUUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

0

2. Health

2.1 Basic Checks

SUUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SUUN has more shares outstanding
SUUN has a worse debt/assets ratio than last year.
SUUN Yearly Shares OutstandingSUUN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M 25M
SUUN Yearly Total Debt VS Total AssetsSUUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

SUUN has an Altman-Z score of 0.59. This is a bad value and indicates that SUUN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.59, SUUN is not doing good in the industry: 82.35% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.54 is on the high side and indicates that SUUN has dependencies on debt financing.
With a Debt to Equity ratio value of 1.54, SUUN is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF N/A
Altman-Z 0.59
ROIC/WACCN/A
WACC9.01%
SUUN Yearly LT Debt VS Equity VS FCFSUUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 0.97 indicates that SUUN may have some problems paying its short term obligations.
SUUN has a Current ratio of 0.97. This is in the lower half of the industry: SUUN underperforms 70.59% of its industry peers.
A Quick Ratio of 0.75 indicates that SUUN may have some problems paying its short term obligations.
SUUN has a worse Quick ratio (0.75) than 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.75
SUUN Yearly Current Assets VS Current LiabilitesSUUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

7

3. Growth

3.1 Past

The earnings per share for SUUN have decreased strongly by -406.17% in the last year.
SUUN shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.76%.
The Revenue has been growing by 99.55% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-406.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2772.73%
Revenue 1Y (TTM)43.76%
Revenue growth 3Y99.55%
Revenue growth 5YN/A
Sales Q2Q%-78.03%

3.2 Future

Based on estimates for the next years, SUUN will show a very strong growth in Earnings Per Share. The EPS will grow by 98.39% on average per year.
The Revenue is expected to grow by 48.23% on average over the next years. This is a very strong growth
EPS Next Y143.84%
EPS Next 2Y138.15%
EPS Next 3Y98.39%
EPS Next 5YN/A
Revenue Next Year59.37%
Revenue Next 2Y60.94%
Revenue Next 3Y48.23%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SUUN Yearly Revenue VS EstimatesSUUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
SUUN Yearly EPS VS EstimatesSUUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0.1 0.2 0.3 0.4 0.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SUUN. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 6.10, the valuation of SUUN can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SUUN indicates a rather cheap valuation: SUUN is cheaper than 100.00% of the companies listed in the same industry.
SUUN is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.1
SUUN Price Earnings VS Forward Price EarningsSUUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SUUN indicates a slightly more expensive valuation: SUUN is more expensive than 68.63% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 59.21
SUUN Per share dataSUUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

SUUN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SUUN's earnings are expected to grow with 98.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y138.15%
EPS Next 3Y98.39%

More info and screens

0

5. Dividend

5.1 Amount

SUUN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SOLARBANK CORP

NASDAQ:SUUN (5/30/2025, 8:00:00 PM)

After market: 1.58 +0.07 (+4.64%)

1.51

-0.04 (-2.58%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)09-29 2025-09-29
Inst Owners0.3%
Inst Owner ChangeN/A
Ins Owners16.94%
Ins Owner ChangeN/A
Market Cap52.90M
Analysts82
Price Target4.89 (223.84%)
Short Float %0.82%
Short Ratio0.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.22%
PT rev (3m)-15.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)184.95%
EPS NY rev (1m)0%
EPS NY rev (3m)200%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-23.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-20.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.1
P/S 1.4
P/FCF N/A
P/OCF N/A
P/B 1.57
P/tB N/A
EV/EBITDA 59.21
EPS(TTM)-0.18
EYN/A
EPS(NY)0.25
Fwd EY16.39%
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS1.08
BVpS0.96
TBVpS-0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.03%
ROE -12.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.27%
FCFM N/A
ROA(3y)-0.64%
ROA(5y)N/A
ROE(3y)-3.92%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.59%
GM growth 5YN/A
F-Score1
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF N/A
Debt/EBITDA 33.31
Cap/Depr 386.79%
Cap/Sales 25.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.75
Altman-Z 0.59
F-Score1
WACC9.01%
ROIC/WACCN/A
Cap/Depr(3y)1403.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.48%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-406.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2772.73%
EPS Next Y143.84%
EPS Next 2Y138.15%
EPS Next 3Y98.39%
EPS Next 5YN/A
Revenue 1Y (TTM)43.76%
Revenue growth 3Y99.55%
Revenue growth 5YN/A
Sales Q2Q%-78.03%
Revenue Next Year59.37%
Revenue Next 2Y60.94%
Revenue Next 3Y48.23%
Revenue Next 5YN/A
EBIT growth 1Y53.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year553.43%
EBIT Next 3Y415.16%
EBIT Next 5YN/A
FCF growth 1Y-40.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y254.89%
OCF growth 3YN/A
OCF growth 5YN/A